UCN-01 is a broad range kinase inhibitor that can inhibit Chk1 and Chk2 (in addition to other kinases) and that has been tested in clinical cancer trials with chemotherapy and/or radiation [9], [10]. The gene discussed is CHEK2; the disease is cancer.